The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Regulatory News (ELTA)

  • There is currently no data for ELTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Tender Offer

22 Dec 2016 07:00

RNS Number : 5507S
Electra Private Equity PLC
22 December 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO AUSTRALIA, CANADA, JAPAN, NEW ZEALAND AND SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

22 December 2016

 

Electra Private Equity PLC

Results of Tender Offer

 

Electra Private Equity PLC (the "Company") today announces the final results of the Tender Offer, details of which were set out in the circular to Shareholders published by the Company on 8 November 2016 (the "Circular"). The Tender Offer closed at 6.00 p.m. on 21 December 2016.

The Strike Price is 4,650 pence and a total of 1,987,768 Ordinary Shares were validly tendered under the Tender Offer. Accordingly all valid tenders will be satisfied in full and the total consideration payable under the Tender Offer is £92,431,212.

It is anticipated that the proceeds payable to the Company's Qualifying Shareholders for the certificated Ordinary Shares purchased under the Tender Offer will be despatched in the form of cheques from 30 December 2016 and that CREST account holders will have their CREST accounts credited from 23 December 2016. Shareholders on the Register on 16 December 2016 will also be paid the interim dividend of 110 pence per Ordinary Share on 19 January 2017.

As set out in the Circular, the Ordinary Shares will be purchased by Morgan Stanley pursuant to the Tender Offer and the Company will buy back such Ordinary Shares from Morgan Stanley (assuming that the put option or call option is exercised under the Tender Offer and Option Agreement entered into between Morgan Stanley, HSBC and the Company). The Company intends to cancel such Ordinary Shares following such repurchase, thereby reducing its total share capital from 40,270,531 Ordinary Shares to 38,282,763 Ordinary Shares (of which no Ordinary Shares will be held in treasury).

On a pro-forma basis the impact of the Tender Offer on the net asset value per Ordinary Share as at 30 September 2016 (unadjusted for events after that date other than the Tender Offer) would be to increase it from 5,149 pence to 5,175 pence.

Neil Johnson (Chairman) commented:

"The Board is gratified to note that the results of the tender offer suggest shareholders have confidence in the strategic direction of the Company. As indicated previously, the Board will consult with Shareholders over its future capital allocation policy and the utilisation of its current and future cash resources."

Capitalised terms used in this announcement (unless otherwise defined) have the same meaning as ascribed to them in the Circular.

This announcement contains inside information.

For further information, please contact:

HSBC Bank plcSimon AlexanderAlex ThomasThomas PinksTel +44 20 7991 8888

Morgan StanleyAndrew FosterSam McLennanRichard BrownTel: +44 20 7425 8000

Brunswick Group LLPGill Ackers/Kim FletcherElectra@brunswickgroup.comTel: +44 20 7404 5959

Gavin MansonChief Financial OfficerElectra Private Equity PLC

 

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase or subscribe for any Ordinary Shares nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefor.

HSBC and Morgan Stanley, each of whom is authorised by the Prudential Regulation Authority and regulated by the Prudential Regulation Authority and the Financial Conduct Authority, are acting for the Company and no one else in connection with the Tender Offer and the Rule 9 Waiver Resolution and HSBC and Morgan Stanley, their affiliates and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to anyone other than the Company for providing the protections afforded to their clients nor for providing advice in connection with the Tender Offer, the Waiver or any other matters or arrangements referred to in this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENFEUEFFFMSEDE
Date   Source Headline
16th Jun 20217:00 amRNSTrading update and company announcement
14th Jun 202110:58 amRNSHalf-year Report
1st Jun 20218:00 amRNSTotal Voting Rights
28th May 202110:39 amRNSAnalyst Note produced by HSBC Global Research
26th May 202110:01 amRNSEdison issues update on Electra Private Equity
24th May 20212:26 pmRNSReplacement: Holding(s) in Company
24th May 20211:41 pmRNSHolding(s) in Company
24th May 20211:27 pmRNSDirector/PDMR Shareholding
24th May 20211:27 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSIssue of Equity
21st May 20211:00 pmRNS2021 Half Year Report Supplementary Information
21st May 20217:00 amRNSHalf-year Report
19th Apr 20217:00 amRNSEdison issues update on Electra Private Equity
15th Apr 20217:00 amRNSDisposal of Sentinel and Portfolio Trading Update
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:35 pmRNSPrice Monitoring Extension
22nd Mar 20213:07 pmRNSHolding(s) in Company
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:35 pmRNSPrice Monitoring Extension
5th Mar 20214:49 pmRNSDirector/PDMR Shareholding
4th Mar 20215:03 pmRNSDirector/PDMR Shareholding
4th Mar 202110:39 amRNSAGM Statement
3rd Mar 20215:21 pmRNSDirector/PDMR Shareholding
24th Feb 20214:45 pmRNSResult of AGM
24th Feb 20217:00 amRNSAGM Statement
26th Jan 20213:10 pmRNSAnnual Report and Notice of Annual General Meeting
17th Dec 20204:41 pmRNSEdison initiates on Electra Private Equity (ELTA)
17th Dec 20208:51 amEQSElectra Private Equity (ELTA): Innovating, restructuring and realising
16th Dec 202012:10 pmRNSEdison Investment Research note
9th Dec 20207:00 amRNSFinal Results
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 202010:33 amRNSPress speculation re Hotter Shoes
27th Aug 202011:37 amRNSConfirmation of Reduction of Capital
27th Aug 20207:00 amRNSExpiry of Hotter Shoes CVA Challenge Period
26th Aug 20209:08 amRNSHolding(s) in Company
29th Jul 202011:29 amRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSCompany update including outcome of Hotter CVA
19th Jun 20202:41 pmRNSHotter Shoes Restructure
19th Jun 20201:33 pmRNSResult of General Meeting
12th Jun 20202:44 pmRNSHalf-year Report
22nd May 20205:02 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSNotice of General Meeting re reduction of capital
21st May 20207:00 amRNSHalf-year Report
1st May 20202:14 pmRNSDisclosure of rights attached to equity shares
20th Mar 20207:00 amRNSUpdate in respect of the COVID-19 situation
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
17th Mar 202011:47 amRNSHolding(s) in Company
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.